NTRA Natera, Inc.
Natera, Inc. (NTRA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $5.9M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Rabinowitz Matthew 6 fills | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 50,000 | $327.97 | $16.4M | 2,274,594 −2.2% of holding | |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 15,160 | $326.89 | $5.0M | 110,859 −12% of holding | |
| Moshkevich Solomon 3 fills | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 3,000 | $320.73 | $962.2K | 128,019 −2.3% of holding | |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sell 10b5-1 | 1,698 | $320.99 | $545.0K | 98,199 −1.7% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.